HOME >> MEDICINE >> NEWS
Implantable cardioverter-defibrillator generator replacement associated with complications

Implantable cardioverter-defibrillator (ICD) generator replacement in Canadian patients with devices that were recalled was associated with an 8 percent rate of complications, according to a study in the April 26 issue of JAMA.

Potential and actual ICD malfunctions caused by failure of generator components, once made public, are known as ICD advisories. ICD advisories potentially affect a large number of patients, according to background information in the article. These advisories or recalls stem from unanticipated failures of ICD generator components that potentially place the patient at risk and are recognized after commercial release and clinical use. Few data are available to guide physicians in the appropriateness of their response to risk imposed by these advisories or to quantify the complication rate associated with ICD generator replacement.

Paul A. Gould, M.B.B.S., Ph.D., and Andrew D. Krahn, M.D., of the University of Western Ontario, London, quantified the complications arising from ICD device replacement resulting directly from the current device advisories. The study included 17 ICD implanting centers in Canada, which were surveyed to assess complication rates as a result of generator replacements because of ICD advisories from October 2004 to October 2005.

During the period of the survey, 2,915 patients had recall devices, including 533 (18.3 percent) patients who underwent elective replacement of an advisory device at an average of 26.5 months after initial ICD implant. Complications directly attributable to elective advisory device replacement occurred in 43 patients (8.1 percent) during an average of 2.7 months' follow-up. Twelve of these were minor complications (2.3 percent). The incidence of major complications was 5.8 percent. Two patients died after ICD replacement led to infection requiring system extraction (0.38 percent of all replacements).

"In conclusion, ICD generator replacement in patients with adviso
'"/>

Contact: Julia Capaldi
519-646-6100
JAMA and Archives Journals
25-Apr-2006


Page: 1 2

Related medicine news :

1. Implantable defibrillators save lives but may increase heart failure risk
2. Implantable cardioverter-defibrillators have higher malfunction rate than pacemakers
3. Implantable pumps extend lives of patients too sick for transplant
4. Implantable pacemaker-like device sends pulses to the brain to treat chronic depression
5. Implantable chips bear promise, but privacy standards needed
6. Clinical guidelines for recalled pacemakers and implantable cardioverter-defibrillators developed
7. Practice makes perfect when implanting cardioverter-defibrillator devices
8. Implanting dopamine generators in brain cells obtains improvement in Parkinsons in monkeys
9. Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy
10. SCAI Founders Lecture highlights remarkable progress in catheter-based aortic valve replacement
11. Percutaneous aortic valve replacement safe, successful in high-risk patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
Cached News: